feed,title,long_url,short_url
Benzinga,Akero Therapeutics Shares More Than Double After Lead NASH Candidate Aces Mid-Stage Study,https://benzinga.com/general/biotech/22/09/28844299/akero-therapeutics-shares-skyrocket-after-lead-nash-candidate-aces-mid-stage-study,https://bit.ly/3RFvDxD
